Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coal tar added to topical corticosteroids for moderate to severe atopic dermatitis
NL-OMON43163Phase 4Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2017
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of coal tar in atopic dermatitis (AD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Percentage change in EASI score at week 2. Planned start Jan 2017; status: withdrawn.
02
Drugs
coal tar
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON43163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43163.